Abbott Laboratories (ABT) has a MoatMap StockRank of 58/100 based on Quality (64/100), Value (44/100), and Momentum (35/100) factor scores. The current signal is HOLD. Abbott Laboratories is a high-quality healthcare giant with diversified revenue streams. However, it lacks a specific, high-velocity macro tailwind from our identified themes to drive asymmetric 18-month outperformance.
Abbott Laboratories is a diversified global healthcare company engaged in the discovery, development, manufacturing, and sale of a broad array of medical products across four segments: Diagnostics, Medical Devices, Nutritionals, and Established Pharmaceuticals. The company's formidable competitive moat stems from its diverse product portfolio addressing critical health needs, robust R&D pipeline, strong global brand recognition for products like FreeStyle Libre, and extensive regulatory and manufacturing expertise. This broad reach and innovation secure its leadership across multiple essential healthcare markets.
| Price | $90.68 |
| Market Cap | $186.3B |
| P/E (TTM) | 25.43 |
| P/E (Forward) | 14.98 |
| Price/Book | 3.04 |
| Return on Equity | 12.3% |
| Return on Invested Capital | 12.8% |
| Debt/Equity | 64.77 |
| Gross Margin | 56.5% |
| Operating Margin | 13.5% |
| Revenue Growth | 7.8% |
| Dividend Yield | 2.8% |
| Free Cash Flow | $6.3B |
Abbott Laboratories operates in the Medical Devices industry, part of the Healthcare sector (United States).